Alfred Mann Institute for Biomedical Development

The Alfred Mann Institute for Biomedical Development (AMI) is a non-profit medical technology incubator designed to accelerate the commercialization of innovative biomedical research. Established by entrepreneur Alfred E. Mann, the institute operates primarily through its flagship location at the University of Southern California (AMI-USC) and its international branch at Technion in Israel. AMI specializes in the development of sophisticated medical devices, including implantable neurostimulators, bionic vision systems, and advanced drug delivery platforms. By providing substantial financial resources and regulatory guidance, the institute bridges the gap between academic discovery and clinical application. Its successful spin-offs have produced market-leading technologies in ophthalmology, audiology, and diabetes management.